Phibro Animal Health (PAHC) Cost of Revenue (2012 - 2026)

Phibro Animal Health has reported Cost of Revenue for 15 years, with the latest figure at $262.3 million in Q2 2026.

• On a quarterly basis, Cost of Revenue fell 2.36% year-over-year to $262.3 million in Q2 2026; TTM through Jun 2026 was $1.0 billion, a 12.2% increase from a year earlier, with the FY2026 full-year figure at $1.0 billion, up 12.2% from the prior year.
• Cost of Revenue was $262.3 million for Q2 2026 at Phibro Animal Health, up from $257.9 million in the prior quarter.
• The five-year high for Cost of Revenue was $268.7 million in Q2 2025, with the low at $163.6 million in Q3 2023.
• Average Cost of Revenue over 5 years is $201.7 million, with a median of $181.0 million recorded in 2023.
• The sharpest annual moves came in 2025 and 2026: Cost of Revenue surged 44.45% in 2025, then dropped 2.36% in 2026.
• Over 5 years, Cost of Revenue stood at $167.3 million in 2022, then grew by 2.43% to $171.3 million in 2023, then climbed by 21.05% to $207.4 million in 2024, then gained by 16.33% to $241.3 million in 2025, then increased by 8.74% to $262.3 million in 2026.
• The last three Cost of Revenue figures came in at $262.3 million (Q2 2026), $257.9 million (Q1 2026), and $241.3 million (Q4 2025), per Business Quant data.